Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.

Villaronga MÁ, Hermida-Prado F, Granda-Díaz R, Menéndez ST, Álvarez-Teijeiro S, Quer M, Vilaseca I, Allonca E, Garzón-Arango M, Sanz-Moreno V, Astudillo A, Rodrigo JP, García-Pedrero JM.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):805-813. doi: 10.1158/1055-9965.EPI-17-1082. Epub 2018 Apr 13.

PMID:
29654156
2.

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.

Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, Allonca E, Pedregal Mallo D, Astudillo A, García-Pedrero JM.

Sci Rep. 2017 Sep 11;7(1):11110. doi: 10.1038/s41598-017-11709-9.

3.

Prognostic significance of E-cadherin and β-catenin expression in HPV-negative oropharyngeal squamous cell carcinomas.

García-Pedrero JM, García-Cabo P, Ángeles Villaronga M, Hermida-Prado F, Granda-Díaz R, Allonca E, Rodrigo JP.

Head Neck. 2017 Nov;39(11):2293-2300. doi: 10.1002/hed.24897. Epub 2017 Aug 17.

PMID:
28815780
4.

Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.

de Vicente JC, Peña I, Rodrigo JP, Rodríguez-Santamarta T, Lequerica-Fernández P, Suárez-Fernández L, Allonca E, García-Pedrero JM.

Head Neck. 2017 Sep;39(9):1876-1887. doi: 10.1002/hed.24854. Epub 2017 Jul 4.

PMID:
28675642
5.

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.

Martinez-Cruzado L, Tornin J, Rodriguez A, Santos L, Allonca E, Fernandez-Garcia MT, Astudillo A, Garcia-Pedrero JM, Rodriguez R.

Neoplasia. 2017 Jun;19(6):460-470. doi: 10.1016/j.neo.2017.03.004. Epub 2017 May 8.

6.

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.

García-Carracedo D, Villaronga MÁ, Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E, Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, Martínez-Camblor P, Su GH, Rodrigo JP, García-Pedrero JM.

Oncotarget. 2016 May 17;7(20):29780-93. doi: 10.18632/oncotarget.8957.

7.

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.

Tornin J, Martinez-Cruzado L, Santos L, Rodriguez A, Núñez LE, Oro P, Hermosilla MA, Allonca E, Fernández-García MT, Astudillo A, Suarez C, Morís F, Rodriguez R.

Oncotarget. 2016 May 24;7(21):30935-50. doi: 10.18632/oncotarget.8817.

8.

Expression of the voltage-gated potassium channel Kv3.4 in oral leucoplakias and oral squamous cell carcinomas.

Fernández-Valle Á, Rodrigo JP, García-Pedrero JM, Rodríguez-Santamarta T, Allonca E, Lequerica-Fernández P, de Vicente JC.

Histopathology. 2016 Jul;69(1):91-8. doi: 10.1111/his.12917. Epub 2016 Feb 28.

PMID:
26648458
9.

Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

de Vicente JC, Santamarta TR, Rodrigo JP, García-Pedrero JM, Allonca E, Blanco-Lorenzo V.

Virchows Arch. 2015 May;466(5):549-58. doi: 10.1007/s00428-015-1746-3. Epub 2015 Mar 1.

PMID:
25726183
10.

Establishment and genetic characterization of six unique tumor cell lines as preclinical models for sinonasal squamous cell carcinoma.

García-Inclán C, López-Hernández A, Alonso-Guervós M, Allonca E, Potes S, Melón S, López F, Llorente JL, Hermsen M.

Sci Rep. 2014 May 12;4:4925. doi: 10.1038/srep04925.

11.

Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas.

Rodrigo JP, Martínez P, Allonca E, Alonso-Durán L, Suárez C, Astudillo A, García-Pedrero JM.

Clin Exp Metastasis. 2014 Mar;31(3):317-25. doi: 10.1007/s10585-013-9630-5. Epub 2013 Dec 27.

PMID:
24370715
12.

Podoplanin expression in oral leukoplakia: tumorigenic role.

de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, Lequerica-Fernández P, Allonca E, García-Pedrero JM.

Oral Oncol. 2013 Jun;49(6):598-603. doi: 10.1016/j.oraloncology.2013.02.008. Epub 2013 Mar 7.

PMID:
23473850
13.

Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma.

de Vicente JC, Rosado P, Lequerica-Fernández P, Allonca E, Villallaín L, Hernández-Vallejo G.

Head Neck. 2013 Jun;35(6):826-30. doi: 10.1002/hed.23038. Epub 2012 Jul 17.

PMID:
22807117
14.

E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.

Rosado P, Lequerica-Fernández P, Fernández S, Allonca E, Villallaín L, de Vicente JC.

Br J Oral Maxillofac Surg. 2013 Mar;51(2):149-56. doi: 10.1016/j.bjoms.2012.03.018. Epub 2012 Apr 21.

PMID:
22525043
15.

Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.

Menéndez ST, Rodrigo JP, Alvarez-Teijeiro S, Villaronga MÁ, Allonca E, Vallina A, Astudillo A, Barros F, Suárez C, García-Pedrero JM.

Mod Pathol. 2012 Aug;25(8):1069-78. doi: 10.1038/modpathol.2012.63. Epub 2012 Mar 30.

16.

Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions.

de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, Lequerica-Fernández P, Allonca E, García-Pedrero JM.

Oral Oncol. 2012 Jul;48(7):641-6. doi: 10.1016/j.oraloncology.2012.02.004. Epub 2012 Feb 28.

PMID:
22377015
17.

Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy.

Rodrigo JP, Álvarez-Alija G, Menéndez ST, Mancebo G, Allonca E, García-Carracedo D, Fresno MF, Suárez C, García-Pedrero JM.

Cancer Prev Res (Phila). 2011 Aug;4(8):1333-41. doi: 10.1158/1940-6207.CAPR-10-0338. Epub 2011 Jun 6.

18.

Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma.

Rodrigo JP, Lequerica-Fernández P, Rosado P, Allonca E, García-Pedrero JM, de Vicente JC.

Head Neck. 2011 Dec;33(12):1708-14. doi: 10.1002/hed.21661. Epub 2011 Apr 15.

PMID:
21500302
19.

Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas.

Rodrigo JP, García-Pedrero JM, Llorente JL, Fresno MF, Allonca E, Suarez C, Hermsen M.

Hum Pathol. 2011 Jan;42(1):88-94. doi: 10.1016/j.humpath.2010.05.017. Epub 2010 Oct 20.

PMID:
20970165
20.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
21.

Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.

Hermsen MA, Sevilla MA, Llorente JL, Weiss MM, Grimbergen A, Allonca E, Garcia-Inclán C, Balbín M, Suárez C.

Cell Oncol. 2010 Jan 1;32(4):275-83. doi: 10.3233/CLO-2009-0498.

22.

Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.

Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.

J Pathol. 2009 Mar;217(4):516-23. doi: 10.1002/path.2462.

PMID:
18991334
23.

Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression.

Canel M, Secades P, Garzón-Arango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V, Chiara MD.

Br J Cancer. 2008 Apr 8;98(7):1274-84. doi: 10.1038/sj.bjc.6604286. Epub 2008 Mar 18.

Supplemental Content

Loading ...
Support Center